None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA I and ASA II participants. 2. Patients undergoing orthopaedic lower limb surgeries. 3. Patients undergoing lower umbilical general surgeries. 4. Women undergoing gynaecological surgeries. 5. Age-18-60 years. 6.weight-40kg to 80kg. 7.Height-150 cm and above.
Exclusion criteria
Exclusion criteria: 1.Patientâ??s refusal . 2.Patients with contraindication for specified drugs. 3.Obesity (BMI >30). 4.Pregnant patients. 5.Infection at the site of injection (spinal). 6.Coagulopathy or any other bleeding diasthesis. 7.Severe hypovolemia. 8.Increased intracranial pressure. 9.Structural and functional cardiac abnormalities. 10.Severe spinal deformity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate & compare the following factors in two groups-intrathecal dexmedetomidine & intrathecal buprenorphine as an adjuvant to hyperbaric bupivacaine in infraumbilical surgeries with respect to: 1. Sensory & motor blockade -onset & duration. Timepoint: Time at which intrathecal drug is administered is T0, followed by T1 at 1min,T2 at 3 min,T3 at 5 min interval......till intraoperative period followed by time required for regaining of sensory and motor sensation in postoperative period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of analgesiaTimepoint: perioperative to postoperative period | — |
Countries
India
Contacts
Silchar Medical College and Hospital